You are here

Home › Listings › Life Sciences › Avisa Diagnostics Inc.

Avisa Diagnostics Inc.

Avisa Diagnostics Inc.
Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Life Sciences
Symbol: 
AVBT
CSE Index: 
Currency: 

A breath biomarker company developing a rapid, point-of-care test to detect pulmonary infections.

You are here

Home

Avisa Diagnostics Inc. (AVBT)

SEDAR Information

Search form

Company Info

Address
1199 West Hastings St., Suite 1400
Vancouver, BC V6E 3T5
Canada
Phone
610-947-0360
Email
[email protected]
Website
https://www.avisadx.com
Listing date
Tuesday, May 29, 2018
Transfer Agent
TSX Trust Company

Capitalization

Issued & Outstanding: 
59,567,784
Reserved for Issuance: 
10,300,360

Company Officers

David Joseph, Chairman, President, Chief Executive Officer and Director
G. Michael Landis, Vice President, Chief Financial Officer and Corporate Secretary

News Releases

24/11/2021

Press Release Reports on Status of Interim Filings

01/09/2021

Press Release Announcing Appointment of Dr. Richard Murray as Chief Medical Officer

Bulletins

13/07/2023

2023-0717 - Delist - Avisa Diagnostics Inc. (AVBT)

le 13 juillet/July 2023

The common shares of Avisa Diagnostics Inc. will be delisted from the CSE at market close on July 13, 2023.

Avisa Diagnostics Inc. is currently suspended. See bulletin 2021-1207.

___________________________

CSE Filings

Material Change Report

Form 7-Monthly Progress Report October 2021

Form 7 - Monthly Progress Report September 2021

Form 7 - Monthly Progress Report August 2021

MD&A for the quarter ended June 30, 2021